UPDATE 1-EU regulators back approval of Gilead's new hep C drug
May 27, 2016 at 08:07 AM EDT
May 27 (Reuters) - An advisory panel to the European drug regulator recommended an approval for Gilead Sciences Inc's new drug combination to treat hepatitis C.
